This content is from: Patents

FTC sues AbbVie over “baseless patent infringement lawsuits”

The Federal Trade Commission (FTC) has filed a complaint in federal district court charging pharmaceutical companies AbbVie and Besins Healthcare with illegally blocking US consumers’ access to lower-cost versions of the blockbuster drug AndroGel

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial